investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Short-form Ron Kinase in Tumor Progression and Metastasis
Alana L Welm
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Brian Raught
University Health Network
Toronto, Canada
Ontario Institute for Cancer Research
Toronto, Canada
Alana L Welm
Oklahoma Medical Research Foundation
Oklahoma City, United States
Related projects
Joan Massague
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression
Breast
Dimitar B Nikolov
Function-blocking anti-ADAM protease antibodies for inhibition of tumorigenesis - NY
Breast
Stuart Keith Calderwood
Extracellular Hsp70 and hyperthermia in tumor therapy
Breast
Douglas C Marchion
Development of a Genomic Expression Signature Associated with Chemoresistance
Breast
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast
David H Haussler
Center for Big Data in Translational Genomics
Breast
Claudia Palena
Novel Targets for Vaccine Therapy
Breast
Areti Strati
Molecular Characterization of CTC in Prostate Cancer
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast